Julien Lemaitre
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Julien Lemaitre has a total of 219 co-authors. Here are the top co-authors by number of shared publications:
- Roger Le Grand
Paris-Saclay University, INSERM, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT/UMRS1184)
13 shared publications - Francis Relouzat
Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France
6 shared publications - Pauline Maisonnasse
Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA
5 shared publications - Thibaut Naninck
Université Paris-Saclay, INSERM, CEA, Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184)
5 shared publications Vanessa Contreras
Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Université Paris-Saclay – Inserm - CEA, Fontenay-aux-Roses & Le Kremlin-Bicêtre, France
5 shared publicationsCamille Ludot
Immune Diseases, Microbiology and Innovative Therapies (IDMIT/UMRS1184), Université Paris-Saclay – Inserm - CEA, Fontenay-aux-Roses & Le Kremlin-Bicêtre, France
4 shared publications
Latest Publications
- Open Access
- 7 June 2026
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (6)
Disease progression is associated with differential neutrophil maturation in Mycobacterium tuberculosis –infected macaques
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is associated with clinical diversity and outcomes ranging from latent TB to active TB with distinct pathophysiologies. However, our understanding of the innate immune mechanisms related to the protection or progression of TB is limited. Among innate immune cells, the role of neutrophils is not fully elucidated, as they have been shown to exhibit both protective and harmful capacities in TB. We hypothesized that Mtb infection induces changes in neutrophil phenotype and function, influencing the infection outcomes. Based on clinical, bacteriological, and positron emission tomography with x-ray computed tomography (PET/CT) scan parameters, cynomolgus macaques infected by Mtb were stratified into two categories: animals that rapidly progressed to an active form of TB, designated as “fast progressors,” and “slow progressors,” which include low symptomatic or asymptomatic animals. In this study, we identified transcriptomic signatures of type I interferons and neutrophil degranulation in macaques with fast progression to active TB, which were not observed in animals with slow TB progression. Unsupervised mass cytometry analysis showed the emergence of blood immature neutrophils (CD101+ CD10−) in fast-progressing animals. In addition, bulk blood neutrophils from infected animals displayed capacities to modulate TNF-α production and cytotoxic function of CD8 T cells in a contact-dependent mechanism. In lung granulomas, neutrophils showed a tissue-specific phenotype (CD101− CD10+), with greater infiltration in animals with active TB. These data suggest that neutrophil subpopulations are associated with disease progression, with capacities to modulate CD8 T cells’ functions, which in turn may contribute to disease progression.
- 7 June 2026
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (6)
Open AccessDisease progression is associated with differential neutrophil maturation in Mycobacterium tuberculosis –infected macaques
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is associated with clinical diversity and outcomes ranging from latent TB to active TB with distinct pathophysiologies. However, our understanding of the innate immune mechanisms related to the protection or progression of TB is limited. Among innate immune cells, the role of neutrophils is not fully elucidated, as they have been shown to exhibit both protective and harmful capacities in TB. We hypothesized that Mtb infection induces changes in neutrophil phenotype and function, influencing the infection outcomes. Based on clinical, bacteriological, and positron emission tomography with x-ray computed tomography (PET/CT) scan parameters, cynomolgus macaques infected by Mtb were stratified into two categories: animals that rapidly progressed to an active form of TB, designated as “fast progressors,” and “slow progressors,” which include low symptomatic or asymptomatic animals. In this study, we identified transcriptomic signatures of type I interferons and neutrophil degranulation in macaques with fast progression to active TB, which were not observed in animals with slow TB progression. Unsupervised mass cytometry analysis showed the emergence of blood immature neutrophils (CD101+ CD10−) in fast-progressing animals. In addition, bulk blood neutrophils from infected animals displayed capacities to modulate TNF-α production and cytotoxic function of CD8 T cells in a contact-dependent mechanism. In lung granulomas, neutrophils showed a tissue-specific phenotype (CD101− CD10+), with greater infiltration in animals with active TB. These data suggest that neutrophil subpopulations are associated with disease progression, with capacities to modulate CD8 T cells’ functions, which in turn may contribute to disease progression.
- 3 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Heterogeneity of polymorphonuclear neutrophils in HIV-1 infection. Study of SIV-infected cynomolgus macaque model.
Hétérogénéité des polynucléaires neutrophiles dans l'infection par le VIH-1.Etude du modèle macaque cynomolgus infecté par le SIV.: La persistance du VIH-1 est associée au maintien de l’inflammation chronique chez les patients infectés, malgré la mise en place de combinaison de traitements antirétroviraux. L’inflammation chronique est associée à un risque augmenté de développer des comorbidités, non associées au SIDA. Les polynucléaires neutrophiles (PNN) sont des cellules myéloïdes qui ont été impliqués dans de multiples maladies inflammatoires chroniques. Néanmoins, leur rôle dans l’infection par le VIH-1 est moins bien connue. Afin de pallier ce manque de connaissances, nous avons évalué l’hétérogénéité des PNNs dans le modèle macaque cynomolgus infecté par le SIVmac251. L’analyse phénotypique par cytométrie de masse a révélé la circulation de PNNs immatures en phase chronique de l’infection. En caractérisant l’hétérogénéité des PNNs au cours de l’infection par le SIV, nous avons observé une augmentation des fréquences des neutrophiles immatures et activés dans le sang dès la primo-infection. En phase chronique, les PNNs immatures et activés étaient toujours significativement augmentés dans le sang et la moelle osseuse. Au cours de l’infection, les PNNs avaient une fonction immunostimulatrice envers la prolifération et la sécrétion cytokinique des lymphocytaire T. L’initiation d’un traitement antirétroviral précoce a permis de restaurer le phénotype des PNNs. Les PNNs sont des cellules à fort potentiel pro-inflammatoire abondantes qui devraient être ainsi considérés comme de nouveaux effecteurs de l’inflammation chronique associée au VIH-1.
- 3 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Heterogeneity of polymorphonuclear neutrophils in HIV-1 infection. Study of SIV-infected cynomolgus macaque model.
Hétérogénéité des polynucléaires neutrophiles dans l'infection par le VIH-1.Etude du modèle macaque cynomolgus infecté par le SIV.: La persistance du VIH-1 est associée au maintien de l’inflammation chronique chez les patients infectés, malgré la mise en place de combinaison de traitements antirétroviraux. L’inflammation chronique est associée à un risque augmenté de développer des comorbidités, non associées au SIDA. Les polynucléaires neutrophiles (PNN) sont des cellules myéloïdes qui ont été impliqués dans de multiples maladies inflammatoires chroniques. Néanmoins, leur rôle dans l’infection par le VIH-1 est moins bien connue. Afin de pallier ce manque de connaissances, nous avons évalué l’hétérogénéité des PNNs dans le modèle macaque cynomolgus infecté par le SIVmac251. L’analyse phénotypique par cytométrie de masse a révélé la circulation de PNNs immatures en phase chronique de l’infection. En caractérisant l’hétérogénéité des PNNs au cours de l’infection par le SIV, nous avons observé une augmentation des fréquences des neutrophiles immatures et activés dans le sang dès la primo-infection. En phase chronique, les PNNs immatures et activés étaient toujours significativement augmentés dans le sang et la moelle osseuse. Au cours de l’infection, les PNNs avaient une fonction immunostimulatrice envers la prolifération et la sécrétion cytokinique des lymphocytaire T. L’initiation d’un traitement antirétroviral précoce a permis de restaurer le phénotype des PNNs. Les PNNs sont des cellules à fort potentiel pro-inflammatoire abondantes qui devraient être ainsi considérés comme de nouveaux effecteurs de l’inflammation chronique associée au VIH-1.
- Open Access
- 24 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Maintenance of intestinal CX3CR1+ macrophage homeostasis defines post-treatment control in SIV-infected macaques
Achieving durable viral remission without antiretroviral therapy (ART) remains a central challenge in HIV-1 cure research. Using a pathogenic SIV model in male cynomolgus macaques, we investigated mucosal and systemic immune features associated with post-treatment control (PTC). Chronic SIV infection disrupts intestinal macrophage homeostasis, skewing the compartment toward a CX3CR1 low inflammatory phenotype marked by increased expression of costimulatory and homing markers. This polarization is associated with mucosal CD4 + T cell depletion, elevated neutrophil activation, and systemic cytokine induction. Non-controllers exhibit a similar inflammatory profile. In contrast, PTCs maintain CX3CR1 high macrophages, preserve regulatory CD4 + T cells, and exhibit attenuated mucosal and systemic immune activation, resembling uninfected animals. CX3CR1 high macrophage abundance inversely correlates with viral burden, T cell activation, and pro-inflammatory cytokines, suggesting a potential role in post-treatment control. These findings identify CX3CR1-expressing intestinal macrophages as a potential biomarker of mucosal immune regulation and highlight their relevance as targets in HIV cure strategies.
- 24 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessMaintenance of intestinal CX3CR1+ macrophage homeostasis defines post-treatment control in SIV-infected macaques
Achieving durable viral remission without antiretroviral therapy (ART) remains a central challenge in HIV-1 cure research. Using a pathogenic SIV model in male cynomolgus macaques, we investigated mucosal and systemic immune features associated with post-treatment control (PTC). Chronic SIV infection disrupts intestinal macrophage homeostasis, skewing the compartment toward a CX3CR1 low inflammatory phenotype marked by increased expression of costimulatory and homing markers. This polarization is associated with mucosal CD4 + T cell depletion, elevated neutrophil activation, and systemic cytokine induction. Non-controllers exhibit a similar inflammatory profile. In contrast, PTCs maintain CX3CR1 high macrophages, preserve regulatory CD4 + T cells, and exhibit attenuated mucosal and systemic immune activation, resembling uninfected animals. CX3CR1 high macrophage abundance inversely correlates with viral burden, T cell activation, and pro-inflammatory cytokines, suggesting a potential role in post-treatment control. These findings identify CX3CR1-expressing intestinal macrophages as a potential biomarker of mucosal immune regulation and highlight their relevance as targets in HIV cure strategies.
- Open Access
Disease progression is associated with differential neutrophil maturation in Mycobacterium tuberculosis-infected macaques
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is associated with clinical diversity and outcomes ranging from latent TB to active TB with distinct pathophysiologies. However, our understanding of the innate immune mechanisms related to the protection or progression of TB is limited. Among innate immune cells, the role of neutrophils is not fully elucidated, as they have been shown to exhibit both protective and harmful capacities in TB. This duality suggests possible differences in the nature and type of neutrophils present during the infection, generating different effects. We hypothesized that Mtb infection induces changes in neutrophil phenotype and function, influencing the infection outcomes. In order to decipher the link between neutrophils and disease progression, we used a cynomolgus macaque model of human TB. Based on clinical, bacteriological, and positron emission tomography with X-ray computed tomography (PET/CT) scan parameters, animals were stratified into two categories: animals that rapidly progressed to an active form of TB, designated as “fast progressors”, and “slow progressors”, which include low symptomatic or asymptomatic animals. In this study, we identified transcriptomic signatures of type I interferons and neutrophil degranulation in macaques with fast progression to active TB, which were not observed in animals with slow TB progression. Unsuppervised mass cytometry analysis showed the emergence of blood immature neutrophils (CD101+ CD10-) in fast progressing animals. In addition, circulating neutrophils from infected animals displayed capacities to modulate TNF-α production and cytotoxic function of CD8 T cells in a contact-dependent mechanism. In the lungs, neutrophils infiltration in granuloma was higher in fast progressors and specifically located in the lymphocyte-rich region in lesions. These data suggest that specific neutrophil’ subpopulations are associated with disease progression. Furthermore, these data suggest that neutrophils may modulate CD8 T cells’ functions, which in turn contribute to the loss of Mtb control and fuel inflammation. AUTHORS SUMMARY: Mycobacterium tuberculosis (Mtb) infection in humans is associated with a wide range of disease progression, ranging from latent tuberculosis (TB) to active TB. Understanding immune factors leading to the control of the infection or disease progression is essential to identify new biomarkers and targets for host-directed therapies. Innate immunity plays an important role in inflammatory imbalance observed in active TB, among which neutrophils have both beneficial and detrimental roles. Using a macaque model developing a broad range of clinical forms of TB, we seek to understand the links between neutrophils and disease progression. We found that rapid progression to active TB leads to type I interferon signalling and neutrophil activation. In the blood, immature neutrophils were enriched when the disease progressed. In case of severe TB, Neutrophils also infiltrate a specific region of lung TB lesions rich in T lymphocytes, whereas they could modulate CD8 T cells. Our study provides new insights into the role of neutrophils in TB progression.
Open AccessDisease progression is associated with differential neutrophil maturation in Mycobacterium tuberculosis-infected macaques
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is associated with clinical diversity and outcomes ranging from latent TB to active TB with distinct pathophysiologies. However, our understanding of the innate immune mechanisms related to the protection or progression of TB is limited. Among innate immune cells, the role of neutrophils is not fully elucidated, as they have been shown to exhibit both protective and harmful capacities in TB. This duality suggests possible differences in the nature and type of neutrophils present during the infection, generating different effects. We hypothesized that Mtb infection induces changes in neutrophil phenotype and function, influencing the infection outcomes. In order to decipher the link between neutrophils and disease progression, we used a cynomolgus macaque model of human TB. Based on clinical, bacteriological, and positron emission tomography with X-ray computed tomography (PET/CT) scan parameters, animals were stratified into two categories: animals that rapidly progressed to an active form of TB, designated as “fast progressors”, and “slow progressors”, which include low symptomatic or asymptomatic animals. In this study, we identified transcriptomic signatures of type I interferons and neutrophil degranulation in macaques with fast progression to active TB, which were not observed in animals with slow TB progression. Unsuppervised mass cytometry analysis showed the emergence of blood immature neutrophils (CD101+ CD10-) in fast progressing animals. In addition, circulating neutrophils from infected animals displayed capacities to modulate TNF-α production and cytotoxic function of CD8 T cells in a contact-dependent mechanism. In the lungs, neutrophils infiltration in granuloma was higher in fast progressors and specifically located in the lymphocyte-rich region in lesions. These data suggest that specific neutrophil’ subpopulations are associated with disease progression. Furthermore, these data suggest that neutrophils may modulate CD8 T cells’ functions, which in turn contribute to the loss of Mtb control and fuel inflammation. AUTHORS SUMMARY: Mycobacterium tuberculosis (Mtb) infection in humans is associated with a wide range of disease progression, ranging from latent tuberculosis (TB) to active TB. Understanding immune factors leading to the control of the infection or disease progression is essential to identify new biomarkers and targets for host-directed therapies. Innate immunity plays an important role in inflammatory imbalance observed in active TB, among which neutrophils have both beneficial and detrimental roles. Using a macaque model developing a broad range of clinical forms of TB, we seek to understand the links between neutrophils and disease progression. We found that rapid progression to active TB leads to type I interferon signalling and neutrophil activation. In the blood, immature neutrophils were enriched when the disease progressed. In case of severe TB, Neutrophils also infiltrate a specific region of lung TB lesions rich in T lymphocytes, whereas they could modulate CD8 T cells. Our study provides new insights into the role of neutrophils in TB progression.
- Open Access
The vaginal microbiota shapes local and systemic inflammation during Chlamydia trachomatis infection in non-human primate
Chlamydiosis, a sexually transmitted infection induced by Chlamydia trachomatis (CT), increases local inflammation (cytokine production, recruitment of neutrophils). Vaginal microbiota (VM) is involved in the regulation of local immune responses and STI acquisition where Lactobacillus spp are associated with protection. In this study, the VM of cynomolgus macaques was enriched with Lactobacillus crispatus after local metronidazole treatment followed by repeated intravaginal inoculations of CT. Metronidazole treatment induced drastic VM modifications (decrease abundance of several anaerobes and increase of natural Lactobacillus spp) . After CT exposure, a non-persisting CT infection and no association between L. crispatus enrichment and a lower CT susceptibility were detected. However, serum specific anti-CT IgG production was higher in treated animals. High concentration of blood cytokines after CT infection was observed in untreated animals, whereas treated animals exhibited an increased production of cervicovaginal cytokines. Blood neutrophils were more mature and activated after CT infection in both groups. These results suggest an efficient local immune response associated with a controlled systemic inflammation (low cytokine production and higher anti-CT IgG titer) upon CT infection in L. crispatus treated animals. This study confirmed that VM composition can be a powerful tool to modulate local immune responses to STIs. Authors summary: Chlamydia trachomatis (CT) is a bacterial pathogen responsible for a highly prevalent sexually transmitted infection (STI), particularly among young women. Often asymptomatic, untreated infections can ascend to the upper genital tract, causing inflammation and, in severe cases, infertility. Environmental factors within the female reproductive tract, including the vaginal microbiota, can influence susceptibility to infection by modulating local immune responses. A non- Lactobacillus spp.-dominated microbiota has been associated with an increased risk of CT acquisition. Using the relevant in vivo model of cynomolgus macaques, which closely resemble humans in terms of immune responses and female reproductive tract anatomy, we investigated the impact of vaginal Lactobacillus crispatus colonization on CT infection. The presence of L. crispatus did not prevent CT acquisition but was associated with increased CT-specific antibody levels. Moreover, systemic inflammation was higher in the non- Lactobacillus -treated group, whereas the opposite trend was observed in the cervicovaginal compartment. This study highlights the critical role of microbiota composition in shaping host immune responses to pathogen infection.
Open AccessThe vaginal microbiota shapes local and systemic inflammation during Chlamydia trachomatis infection in non-human primate
Chlamydiosis, a sexually transmitted infection induced by Chlamydia trachomatis (CT), increases local inflammation (cytokine production, recruitment of neutrophils). Vaginal microbiota (VM) is involved in the regulation of local immune responses and STI acquisition where Lactobacillus spp are associated with protection. In this study, the VM of cynomolgus macaques was enriched with Lactobacillus crispatus after local metronidazole treatment followed by repeated intravaginal inoculations of CT. Metronidazole treatment induced drastic VM modifications (decrease abundance of several anaerobes and increase of natural Lactobacillus spp) . After CT exposure, a non-persisting CT infection and no association between L. crispatus enrichment and a lower CT susceptibility were detected. However, serum specific anti-CT IgG production was higher in treated animals. High concentration of blood cytokines after CT infection was observed in untreated animals, whereas treated animals exhibited an increased production of cervicovaginal cytokines. Blood neutrophils were more mature and activated after CT infection in both groups. These results suggest an efficient local immune response associated with a controlled systemic inflammation (low cytokine production and higher anti-CT IgG titer) upon CT infection in L. crispatus treated animals. This study confirmed that VM composition can be a powerful tool to modulate local immune responses to STIs. Authors summary: Chlamydia trachomatis (CT) is a bacterial pathogen responsible for a highly prevalent sexually transmitted infection (STI), particularly among young women. Often asymptomatic, untreated infections can ascend to the upper genital tract, causing inflammation and, in severe cases, infertility. Environmental factors within the female reproductive tract, including the vaginal microbiota, can influence susceptibility to infection by modulating local immune responses. A non- Lactobacillus spp.-dominated microbiota has been associated with an increased risk of CT acquisition. Using the relevant in vivo model of cynomolgus macaques, which closely resemble humans in terms of immune responses and female reproductive tract anatomy, we investigated the impact of vaginal Lactobacillus crispatus colonization on CT infection. The presence of L. crispatus did not prevent CT acquisition but was associated with increased CT-specific antibody levels. Moreover, systemic inflammation was higher in the non- Lactobacillus -treated group, whereas the opposite trend was observed in the cervicovaginal compartment. This study highlights the critical role of microbiota composition in shaping host immune responses to pathogen infection.
- Open Access
- 1 January 2025
- Published by OpenEdition in Revue de primatologie
- Vol. 16 (16)
Le modèle d’infection SARS-CoV-2 chez le primate non-humain, un outil préclinique pour la compréhension de la physiopathologie et l’évaluation de l’efficacité de candidats thérapeutiques et vaccinaux
L’émergence de maladies infectieuses présentant un risque pour la population humaine requiert des outils et modèles expérimentaux permettant de caractériser ces maladies afin de mieux s’en protéger. Suite à l’apparition du SARS-CoV-2, nous avons mis au point un modèle d’infection chez plusieurs espèces de primate non-humain (babouin olive, macaque rhésus et macaque cynomolgus) afin d’évaluer différents aspects de l’infection. À partir de données recueillies dans notre laboratoire sur plus de 150 primates non-humains, nous avons comparé l’infection SARS-CoV-2 par la souche Wuhan et par plusieurs variants, dont Delta et Omicron. Les analyses montrent que le pic de charge virale a lieu entre 2 et 4 jours après exposition au virus quelle que soit la souche. Cependant, l’intensité du pic et la durée de charge virale détectable sont dépendantes du variant. L’infection induit une diminution transitoire du nombre de lymphocytes ainsi qu’une inflammation avec une élévation d’IL-1RA (antagoniste du récepteur de l’interleukine-1), d’IL-15 (interleukine-15), de CCL-1 (ligand-1 chimiokine motif C-C) et d’haptoglobine dans le plasma. La comparaison des variants montre que le variant Delta entraîne les plus fortes charges virales, ainsi qu’une réponse inflammatoire la plus marquée, tandis que les variants Omicron présentent une virulence atténuée. L’étude des réponses immunitaires a mis en évidence une production d’anticorps spécifiques et neutralisants différente en fonction du variant. Les variants Omicron induisent une réponse humorale plus tardive et moins intense. En revanche, la réponse cellulaire des lymphocytes T montre une forte réactivité croisée, avec une production d’interféron γ (IFN-γ) et d’IL-2 (interleukine-2). Ces travaux confirment la pertinence du macaque cynomolgus comme modèle préclinique pour l’étude du SARS-CoV-2 et l’évaluation de stratégies thérapeutiques et vaccinales. Ce modèle a contribué à l’identification de traitements et vaccins efficaces contre la COVID-19 et continue d’être une référence pour l’étude de l’évolution du virus et des réponses immunitaires associées.
- 1 January 2025
- Published by OpenEdition in Revue de primatologie
- Vol. 16 (16)
Open AccessLe modèle d’infection SARS-CoV-2 chez le primate non-humain, un outil préclinique pour la compréhension de la physiopathologie et l’évaluation de l’efficacité de candidats thérapeutiques et vaccinaux
L’émergence de maladies infectieuses présentant un risque pour la population humaine requiert des outils et modèles expérimentaux permettant de caractériser ces maladies afin de mieux s’en protéger. Suite à l’apparition du SARS-CoV-2, nous avons mis au point un modèle d’infection chez plusieurs espèces de primate non-humain (babouin olive, macaque rhésus et macaque cynomolgus) afin d’évaluer différents aspects de l’infection. À partir de données recueillies dans notre laboratoire sur plus de 150 primates non-humains, nous avons comparé l’infection SARS-CoV-2 par la souche Wuhan et par plusieurs variants, dont Delta et Omicron. Les analyses montrent que le pic de charge virale a lieu entre 2 et 4 jours après exposition au virus quelle que soit la souche. Cependant, l’intensité du pic et la durée de charge virale détectable sont dépendantes du variant. L’infection induit une diminution transitoire du nombre de lymphocytes ainsi qu’une inflammation avec une élévation d’IL-1RA (antagoniste du récepteur de l’interleukine-1), d’IL-15 (interleukine-15), de CCL-1 (ligand-1 chimiokine motif C-C) et d’haptoglobine dans le plasma. La comparaison des variants montre que le variant Delta entraîne les plus fortes charges virales, ainsi qu’une réponse inflammatoire la plus marquée, tandis que les variants Omicron présentent une virulence atténuée. L’étude des réponses immunitaires a mis en évidence une production d’anticorps spécifiques et neutralisants différente en fonction du variant. Les variants Omicron induisent une réponse humorale plus tardive et moins intense. En revanche, la réponse cellulaire des lymphocytes T montre une forte réactivité croisée, avec une production d’interféron γ (IFN-γ) et d’IL-2 (interleukine-2). Ces travaux confirment la pertinence du macaque cynomolgus comme modèle préclinique pour l’étude du SARS-CoV-2 et l’évaluation de stratégies thérapeutiques et vaccinales. Ce modèle a contribué à l’identification de traitements et vaccins efficaces contre la COVID-19 et continue d’être une référence pour l’étude de l’évolution du virus et des réponses immunitaires associées.
- Open Access
- 22 September 2024
- Published by Wiley in Journal of Medical Primatology
- Vol. 53 (5) , e12736
An Experimental Study to Optimize Neuromuscular Blockade Protocols in Cynomolgus Macaques: Monitoring, Doses, and Antagonism
Background: Neuromuscular blocking agents (NMBAs) are a crucial component of anesthesia and intensive care through the relaxation of skeletal muscles. They can lead to adverse reactions such as postoperative residual neuromuscular block. Only one agent is capable of an instant block reversal in deep block situations, but is restricted to aminosteroid agents. Among animal models, non‐human primates are an essential model for a great diversity of human disease models. The main objective of this study was to establish a model for NMBA monitoring with current available drugs before testing new reversal agents.Methods: Seven healthy male cynomolgus macaques were randomly assigned to this study. Experiments using macaques were approved by the local ethical committee (CEtEA #44). All animals were anesthetized according to institutional guidelines, with ketamine and medetomidine, allowing IV line placement and tracheal intubation. Anesthesia was maintained with isoflurane. Either rocuronium bromine (with or without sugammadex reversal) or atracurium besylate was evaluated. Monitoring was performed with two devices, TOF‐Watch and ToFscan, measuring the T4/T1 and the T4/Tref ratios, respectively. Nonparametric Mann–Whitney statistical analyses were done when indicated.Results: NMBA monitoring required adaptation compared to humans, such as stimulus intensity and electrode placement, to be efficient and valid in cynomolgus macaques. When administered, both NMBAs induced deep and persistent neuro‐muscular block at equivalent doses to clinical doses in humans. The rocuronium‐induced profound neuromuscular block could be reversed using the cyclodextrin sugammadex as a reversal agent. We report no adverse effects in these models by clinical observation, blood chemistry, or complete blood count.Conclusion: These results support the use of non‐human primate models for neuromuscular block monitoring. This represented the first step before the forthcoming testing of new NMBA‐reversal agents.
- 22 September 2024
- Published by Wiley in Journal of Medical Primatology
- Vol. 53 (5) , e12736
Open AccessAn Experimental Study to Optimize Neuromuscular Blockade Protocols in Cynomolgus Macaques: Monitoring, Doses, and Antagonism
Background: Neuromuscular blocking agents (NMBAs) are a crucial component of anesthesia and intensive care through the relaxation of skeletal muscles. They can lead to adverse reactions such as postoperative residual neuromuscular block. Only one agent is capable of an instant block reversal in deep block situations, but is restricted to aminosteroid agents. Among animal models, non‐human primates are an essential model for a great diversity of human disease models. The main objective of this study was to establish a model for NMBA monitoring with current available drugs before testing new reversal agents.Methods: Seven healthy male cynomolgus macaques were randomly assigned to this study. Experiments using macaques were approved by the local ethical committee (CEtEA #44). All animals were anesthetized according to institutional guidelines, with ketamine and medetomidine, allowing IV line placement and tracheal intubation. Anesthesia was maintained with isoflurane. Either rocuronium bromine (with or without sugammadex reversal) or atracurium besylate was evaluated. Monitoring was performed with two devices, TOF‐Watch and ToFscan, measuring the T4/T1 and the T4/Tref ratios, respectively. Nonparametric Mann–Whitney statistical analyses were done when indicated.Results: NMBA monitoring required adaptation compared to humans, such as stimulus intensity and electrode placement, to be efficient and valid in cynomolgus macaques. When administered, both NMBAs induced deep and persistent neuro‐muscular block at equivalent doses to clinical doses in humans. The rocuronium‐induced profound neuromuscular block could be reversed using the cyclodextrin sugammadex as a reversal agent. We report no adverse effects in these models by clinical observation, blood chemistry, or complete blood count.Conclusion: These results support the use of non‐human primate models for neuromuscular block monitoring. This represented the first step before the forthcoming testing of new NMBA‐reversal agents.
- 11 September 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (764) , eado4463
Rocuronium-specific antibodies drive perioperative anaphylaxis but can also function as reversal agents in preclinical models
Neuromuscular blocking agents (NMBAs) relax skeletal muscles to facilitate surgeries and ease intubation but can lead to adverse reactions, including complications because of postoperative residual neuromuscular blockade (rNMB) and, in rare cases, anaphylaxis. Both adverse reactions vary between types of NMBAs, with rocuronium, a widely used nondepolarizing NMBA, inducing one of the longest rNMB durations and highest anaphylaxis incidences. rNMB induced by rocuronium can be reversed by the synthetic γ-cyclodextrin sugammadex. However, in rare cases, sugammadex can provoke anaphylaxis. Thus, additional therapeutic options are needed. Rocuronium-induced anaphylaxis is proposed to rely on preexisting rocuronium-binding antibodies. To understand the pathogenesis of rocuronium-induced anaphylaxis and to identify potential therapeutics, we investigated the memory B cell antibody repertoire of patients with suspected hypersensitivity to rocuronium. We identified polyclonal antibody repertoires with a high diversity among V(D)J genes without evidence of clonal groups. When recombinantly expressed, these antibodies demonstrated specificity and low affinity for rocuronium without cross-reactivity for other NMBAs. Moreover, when these antibodies were expressed as human immunoglobulin E (IgE), they triggered human mast cell activation and passive systemic anaphylaxis in transgenic mice, although their affinities were insufficient to serve as reversal agents. Rocuronium-specific, high-affinity antibodies were thus isolated from rocuronium-immunized mice. The highest-affinity antibody was able to reverse rocuronium-induced neuromuscular blockade in nonhuman primates with kinetics comparable to that of sugammadex. Together, these data support the hypothesis that antibodies cause anaphylactic reactions to rocuronium and pave the way for improved diagnostics and neuromuscular blockade reversal agents.
- 11 September 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (764) , eado4463
Rocuronium-specific antibodies drive perioperative anaphylaxis but can also function as reversal agents in preclinical models
Neuromuscular blocking agents (NMBAs) relax skeletal muscles to facilitate surgeries and ease intubation but can lead to adverse reactions, including complications because of postoperative residual neuromuscular blockade (rNMB) and, in rare cases, anaphylaxis. Both adverse reactions vary between types of NMBAs, with rocuronium, a widely used nondepolarizing NMBA, inducing one of the longest rNMB durations and highest anaphylaxis incidences. rNMB induced by rocuronium can be reversed by the synthetic γ-cyclodextrin sugammadex. However, in rare cases, sugammadex can provoke anaphylaxis. Thus, additional therapeutic options are needed. Rocuronium-induced anaphylaxis is proposed to rely on preexisting rocuronium-binding antibodies. To understand the pathogenesis of rocuronium-induced anaphylaxis and to identify potential therapeutics, we investigated the memory B cell antibody repertoire of patients with suspected hypersensitivity to rocuronium. We identified polyclonal antibody repertoires with a high diversity among V(D)J genes without evidence of clonal groups. When recombinantly expressed, these antibodies demonstrated specificity and low affinity for rocuronium without cross-reactivity for other NMBAs. Moreover, when these antibodies were expressed as human immunoglobulin E (IgE), they triggered human mast cell activation and passive systemic anaphylaxis in transgenic mice, although their affinities were insufficient to serve as reversal agents. Rocuronium-specific, high-affinity antibodies were thus isolated from rocuronium-immunized mice. The highest-affinity antibody was able to reverse rocuronium-induced neuromuscular blockade in nonhuman primates with kinetics comparable to that of sugammadex. Together, these data support the hypothesis that antibodies cause anaphylactic reactions to rocuronium and pave the way for improved diagnostics and neuromuscular blockade reversal agents.
- Open Access
Optimization of neuromuscular blockade protocols in cynomolgus macaques: monitoring, doses and antagonism
Background: Neuromuscular blocking agents (NMBAs) are a crucial component of anaesthesia and intensive care. NMBAs are a family of molecules defined by their ability to compete with acetylcholine for binding to the acetylcholine receptor at the neuromuscular junction. This functional homology relies on the presence of ammonium groups in all NMBAs that, however, display vastly different chemical structures. Among animal models, non-human primates (NHP) are an essential model for a great diversity of human disease models but remain poorly characterized for the effectiveness of the diverse NMBAs. Methods: Seven healthy male cynomolgus macaques were randomly assigned to this study. Experiments using macaques were approved by the local ethical committee (CEtEA #44). All animals were anaesthetized according to institutional guidelines, with ketamine and medetomidine, allowing IV line placement and tracheal intubation. Anaesthesia was maintained with isofluorane. Either rocuronium bromine or atracurium besylate was evaluated, with reversal with sugammadex. Monitoring was performed with two devices, TOF-Watch® and ToFscan®, measuring the T4/T1 and the T4/Tref ratios, respectively. Nonparametric Mann-Whitney statistical analyses were done when indicated. Results: NMBA monitoring required adaptation compared to humans, such as stimulus intensity and electrodes placement, to be efficient and valid in Cynomolgus macaques. When administered, both NMBAs induced deep and persistent neuro-muscular blockade at equivalent doses to clinical doses in humans. Rocuronium-induced profound neuromuscular blockade could be reverted using the cyclodextrin sugammadex’s reversal agent. We report no adverse effects in these models by clinical observation, blood chemistry, or complete blood count. Conclusion: These results support the use of non-human primate models for neuromuscular blockade monitoring and testing novel NMBA or their reversal agents.
Open AccessOptimization of neuromuscular blockade protocols in cynomolgus macaques: monitoring, doses and antagonism
Background: Neuromuscular blocking agents (NMBAs) are a crucial component of anaesthesia and intensive care. NMBAs are a family of molecules defined by their ability to compete with acetylcholine for binding to the acetylcholine receptor at the neuromuscular junction. This functional homology relies on the presence of ammonium groups in all NMBAs that, however, display vastly different chemical structures. Among animal models, non-human primates (NHP) are an essential model for a great diversity of human disease models but remain poorly characterized for the effectiveness of the diverse NMBAs. Methods: Seven healthy male cynomolgus macaques were randomly assigned to this study. Experiments using macaques were approved by the local ethical committee (CEtEA #44). All animals were anaesthetized according to institutional guidelines, with ketamine and medetomidine, allowing IV line placement and tracheal intubation. Anaesthesia was maintained with isofluorane. Either rocuronium bromine or atracurium besylate was evaluated, with reversal with sugammadex. Monitoring was performed with two devices, TOF-Watch® and ToFscan®, measuring the T4/T1 and the T4/Tref ratios, respectively. Nonparametric Mann-Whitney statistical analyses were done when indicated. Results: NMBA monitoring required adaptation compared to humans, such as stimulus intensity and electrodes placement, to be efficient and valid in Cynomolgus macaques. When administered, both NMBAs induced deep and persistent neuro-muscular blockade at equivalent doses to clinical doses in humans. Rocuronium-induced profound neuromuscular blockade could be reverted using the cyclodextrin sugammadex’s reversal agent. We report no adverse effects in these models by clinical observation, blood chemistry, or complete blood count. Conclusion: These results support the use of non-human primate models for neuromuscular blockade monitoring and testing novel NMBA or their reversal agents.
- 6 March 2023
- Published by Springer Nature in EMBO Reports
- Vol. 24 (4) , e56055
SARS‐CoV‐2‐related bat virus behavior in human‐relevant models sheds light on the origin of COVID‐19
Bat sarbecovirus BANAL-236 is highly related to SARS-CoV-2 and infects human cells, albeit lacking the furin cleavage site in its spike protein. BANAL-236 replicates efficiently and pauci-symptomatically in humanized mice and in macaques, where its tropism is enteric, strongly differing from that of SARS-CoV-2. BANAL-236 infection leads to protection against superinfection by a virulent strain. We find no evidence of antibodies recognizing bat sarbecoviruses in populations in close contact with bats in which the virus was identified, indicating that such spillover infections, if they occur, are rare. Six passages in humanized mice or in human intestinal cells, mimicking putative early spillover events, select adaptive mutations without appearance of a furin cleavage site and no change in virulence. Therefore, acquisition of a furin site in the spike protein is likely a pre-spillover event that did not occur upon replication of a SARS-CoV-2-like bat virus in humans or other animals. Other hypotheses regarding the origin of the SARS-CoV-2 should therefore be evaluated, including the presence of sarbecoviruses carrying a spike with a furin cleavage site in bats.
- 6 March 2023
- Published by Springer Nature in EMBO Reports
- Vol. 24 (4) , e56055
SARS‐CoV‐2‐related bat virus behavior in human‐relevant models sheds light on the origin of COVID‐19
Bat sarbecovirus BANAL-236 is highly related to SARS-CoV-2 and infects human cells, albeit lacking the furin cleavage site in its spike protein. BANAL-236 replicates efficiently and pauci-symptomatically in humanized mice and in macaques, where its tropism is enteric, strongly differing from that of SARS-CoV-2. BANAL-236 infection leads to protection against superinfection by a virulent strain. We find no evidence of antibodies recognizing bat sarbecoviruses in populations in close contact with bats in which the virus was identified, indicating that such spillover infections, if they occur, are rare. Six passages in humanized mice or in human intestinal cells, mimicking putative early spillover events, select adaptive mutations without appearance of a furin cleavage site and no change in virulence. Therefore, acquisition of a furin site in the spike protein is likely a pre-spillover event that did not occur upon replication of a SARS-CoV-2-like bat virus in humans or other animals. Other hypotheses regarding the origin of the SARS-CoV-2 should therefore be evaluated, including the presence of sarbecoviruses carrying a spike with a furin cleavage site in bats.